Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia corporate presentation – June 2019 from adocia

Latest Press Releases

2019/07/17Adocia Presents First Half 2019 Financial Results
2019/07/11Half year report on Adocia’s liquidity agreement with Kepler Capital Markets

All Press releases

Next events

September 10-16, 2019 55th annual meeting of the European Association for the Study of Diabetes, Barcelona, Spain

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

2 Videos of student “Eloquence contest” of the 135th promotion of ESPCI Paris organized by Adocia

ADA2019: find the two Adocia abstracts including the “BioChaperone® Glucagon Exenatide” Poster online